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Volume 54, Number 6 Abstracts 1855and supraclavicular, have been criticized for incomplete rib resection and
neurovascular complications. We describe a minimally-invasive robotic
transthoracic approach for resection of the first rib with scalenectomy.
Methods:Over a 16 month period, 13 robotic first rib resections were
performed in 9 patients. Preoperative assessment included physical exam
Duplex ultrasound, and venography. All patients were tested for hyperco-
agulability prior to initiating anticoagulation. Based on a thoracoscopic
platform, three 2 cm incisions introduced the robotic arms. The robot was
used to dissect the first rib and divide the scalene muscles. The right robotic
arm was replaced with a thoracoscopic 6 mm kerrison which divided the rib
at its midpoint. The right robotic arm was then re-positioned with the
remainder of the procedure performed robotically. Division at its midpoint
allowed the rib to be pivoted on the sternal and vertebral joints. The rib was
dissected from the scalene muscles and disarticulated at the respective joints.
Postoperative outcomes were assessed by symptom relief, physical examina-
tion, and venography.
Results: Patient demographics included 6 men and 3 women with a
mean age of 34  8 years. Coagulation studies were negative in 5 patients
(56%) and positive in 4 (44%); Factor V Leiden deficiency 1, MTHFR gene
mutation in 3. Operative time was 188  31 minutes. Patients were
anticoagulated with warfarin for 3 months. Four patients underwent post-
operative subclavian vein stent deployment after angioplasty with the addi-
tion of antiplatelet therapy. There were no perioperative complications and
no mortality. At a median follow-up of 8 months, all patients had patent
subclavian veins by venography and all reported being symptomatically
improved.
Conclusions: Robotic transthoracic first rib resection is feasible. The
technique allows for a minimally-invasive en bloc resection of the offending
portion of the first rib with scalenectomy, with no neurovascular complica-
tions in this initial cohort. While greater experience is necessary, this new
approach to first rib resection may allow for a minimally invasive, effective
treatment for patients with Paget-Schroetter syndrome.
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Background: Surgical intervention for patients with neurogenic tho-
acic outlet syndrome (NTOS) does not always yield successful outcomes.
hile several studies have presented the benefits of first rib resection and
calenectomy (FRRS), few have analyzed patients with unresolved, recur-
ent, and/or contralateral neurogenic symptoms following surgical treat-
ent. The purpose of this study was to describe the demographic and clinical
eatures of these patients, and to determine treatment protocols for improv-
ng their outcomes.
Methods: Data on 161 NTOS patients (182 FRRS procedures) was
rospectively collected from 2003-11, and retrospectively reviewed for
vidence of unresolved, recurrent, and/or contralateral neurogenic symp-
oms following FRRS. Demographic and clinical characteristics, pre- and
ostoperative interventions, and outcomes were compared between these
atients and those with an initial successful result.
Results: Group 1: Unresolved Symptoms (n 24; 13%): 23 patients (24
RRS) presented with unresolved symptoms at a mean of 16.1  4.7
ostoperative months. Compared to successes, these patients were older (45
s 38; P .002), active smokers (33% vs 13%; P .031) with higher rates of
hronic pain syndromes (67% vs 14%; P  .001) and neck and/or shoulder
omorbidities (58% vs 22%; P .001). At initial assessment, they reported a
onger duration of symptoms (90 vs 48months; P .005). Etiology favored
rauma (58%) compared to repetitive injury (42%) and preoperative inter-
entions more often included other surgery (50% vs 28%). Patients at high
isk for failure had greater narcotic use (67% vs 31%; P  .001) and more
T-guided Botox injections (46% vs 20%; P  .009) with fewer cases of
elief of symptoms (18% vs 64%; P  .014). The main postoperative
reatments were physical therapy (100%) and local anesthetic and/or steroid
njections (38%). Only 6 (26%) patients achieved freedom from narcotics at
he end of the follow-up period.Group 2: Recurrent Symptoms (n 16; 9%):
6 patients presented with recurrent symptoms at a mean of 12.1 / 9.7
ostoperative months. These patients had higher rates of chronic pain
yndromes (38%; P .028) and neck and/or shoulder comorbidities (50%;
 .027). Recurrence was secondary to scar tissue (69%; P  .001) and
e-injury (31%; P  .002). The main treatment modalities were physical
herapy (94%) and CT-guided Botox injections (38%), where nearly all
94%) patients reported benefit. 13 (81%) patients achieved freedom from
arcotics at the end of the follow-up period. Group 3: Contralateral Symp-
oms (n  21; 13%): 21 patients presented with contralateral symptoms and
nderwent secondary FRRS at a mean of 15.0 (range 7-30) months follow-
ng primary FRRS. The first surgery was successful in nearly all (86%) cases.
tiology was more commonly repetitive injury (67%) compared to trauma
33%).
Conclusions: 1. Patients with unresolved symptoms are older, active
mokers with more comorbid pain syndromes, neck and/or shoulder dis-
ase, and a longer period of symptoms. These patients face a more difficult
ecovery. 2. Patients with recurrent symptoms are well managed with
hysical therapy and CT-guided Botox injections. 3. Patients with contralat-
ral symptoms at 1 year are effectively treated with secondary FRRS. 4.
atients must be followed closely after FRRS to determine if additional
nterventions are necessary to ensure successful results.
New Tool for Extreme IVC Filter Removal
hristopher J. Kwolek, JunaidMalek,Mark Conrad,Mass General Hospital,
oston, Mass
Background: As the use of retrievable filters increases, the need for
idely adaptable techniques to remove embedded IVC filters will increase.
he use of the rigid bronchoscopy forceps allows embedded filters to be
emoved safely in patients who would otherwise have a tilted filter left in
lace permanently. However the rigid straight shaft may prevent the oper-
tor from successfully directing the forceps and grasping the tip of the filter.
e describe the first intravascular use of a steerable laparoscopic grasping
orcep to remove an embedded IVC filter.
Methods: A 58-yo patient was referred 1 yr after undergoing catheter
irected thrombolysis and placement of a retrievable IVC filter for treatment
f DVT/PE. She had undergone an unsuccessful attempt at filter retrieval
ia an Internal Jugular (IJ) approach. CT scan revealed that the tip of the
ard Filter was embedded in the anterior wall of the IVC (Fig 1). A second
nsuccessful attempt at retrieving the filter via an isolated RIJ approach was
erformed using snares, retrieval cones and biopsy forceps. The patient was
eturned to the endovascular suite 1 month later for another attempt using
combined RIJ and Femoral venous approach. The Bard retrieval cone
as introduced via a 12 fr sheath in the RIJ. A novel laparoscopic
enestrated alligator grasper with a steerable tip with 90 degrees deflec-
ion and 360 degrees rotation was introduced via an 18 fr sheath in
emoral vein. The grasper was used to remove the tip of the filter from the
